Joinn Laboratories(China)Co.,Ltd. Stock
Equities
603127
CNE100002W27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.68 CNY | -3.14% | -2.06% | -29.65% |
Sales 2024 * | 2.35B 325M | Sales 2025 * | 2.84B 393M | Capitalization | 11.48B 1.59B |
---|---|---|---|---|---|
Net income 2024 * | 423M 58.43M | Net income 2025 * | 657M 90.75M | EV / Sales 2024 * | 3.62 x |
Net cash position 2024 * | 2.97B 410M | Net cash position 2025 * | 3.69B 510M | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
19
x | Employees | 2,510 |
Yield 2024 * |
0.71% | Yield 2025 * |
1.18% | Free-Float | 59.26% |
1 day | -3.14% | ||
1 week | -2.06% | ||
Current month | +1.77% | ||
1 month | -0.60% | ||
3 months | -4.74% | ||
6 months | -39.81% | ||
Current year | -29.65% |
Managers | Title | Age | Since |
---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 12-10-31 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 19-06-30 |
Ye Li
CHM | Chairman | 42 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 95-08-10 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 96-11-30 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 99-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 2 M€ | -14.64% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 16.68 | -3.14% | 10,944,700 |
24-05-20 | 17.22 | +1.89% | 13,560,450 |
24-05-17 | 16.9 | +1.14% | 12,216,370 |
24-05-16 | 16.71 | +0.18% | 13,489,560 |
24-05-15 | 16.68 | -2.06% | 14,257,950 |
End-of-day quote Shanghai S.E., May 20, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.65% | 1.59B | |
+44.48% | 55.07B | |
-0.86% | 41.79B | |
+44.25% | 40.22B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- 603127 Stock